CN Patent
CN112409256B — 5,7-二氯四氢异喹啉缩醛胺类化合物、其制备方法与应用
Assigned to Shandong Fuchang Pharmaceutical Co ltd · Expires 2024-04-02 · 2y expired
What this patent protects
本发明提供了式III所示的5,7‑二氯四氢异喹啉缩醛胺类化合物、其制备方法及应用。所述式III所示的5,7‑二氯四氢异喹啉类化合物可以用于合成立他司特的关键中间体。本发明具有原子经济性高,副产物少等优点,符合“绿色化学”理念,适合于开发为工业化生产工艺。
USPTO Abstract
本发明提供了式III所示的5,7‑二氯四氢异喹啉缩醛胺类化合物、其制备方法及应用。所述式III所示的5,7‑二氯四氢异喹啉类化合物可以用于合成立他司特的关键中间体。本发明具有原子经济性高,副产物少等优点,符合“绿色化学”理念,适合于开发为工业化生产工艺。
Drugs covered by this patent
- Xiidra (LIFITEGRAST) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.